- Home
- BBIO vs FRHC Comparison
BBIO vs FRHC Comparison
Compare BBIO & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FRHC
- Stock Information
- Founded
- BBIO 2015
- FRHC 1981
- Country
- BBIO United States
- FRHC Kazakhstan
- Employees
- BBIO N/A
- FRHC N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FRHC Investment Bankers/Brokers/Service
- Sector
- BBIO Health Care
- FRHC Finance
- Exchange
- BBIO Nasdaq
- FRHC Nasdaq
- Market Cap
- BBIO 6.7B
- FRHC 7.8B
- IPO Year
- BBIO 2019
- FRHC N/A
- Fundamental
- Price
- BBIO $34.17
- FRHC $156.07
- Analyst Decision
- BBIO Strong Buy
- FRHC
- Analyst Count
- BBIO 12
- FRHC 0
- Target Price
- BBIO $57.09
- FRHC N/A
- AVG Volume (30 Days)
- BBIO 3.1M
- FRHC 65.0K
- Earning Date
- BBIO 04-29-2025
- FRHC 06-13-2025
- Dividend Yield
- BBIO N/A
- FRHC N/A
- EPS Growth
- BBIO N/A
- FRHC N/A
- EPS
- BBIO N/A
- FRHC 5.36
- Revenue
- BBIO $127,415,000.00
- FRHC $1,578,152,000.00
- Revenue This Year
- BBIO $13.67
- FRHC N/A
- Revenue Next Year
- BBIO $118.02
- FRHC N/A
- P/E Ratio
- BBIO N/A
- FRHC $29.06
- Revenue Growth
- BBIO N/A
- FRHC 79.07
- 52 Week Low
- BBIO $21.62
- FRHC $68.82
- 52 Week High
- BBIO $39.47
- FRHC $164.83
- Technical
- Relative Strength Index (RSI)
- BBIO 44.19
- FRHC 69.42
- Support Level
- BBIO $33.92
- FRHC $138.99
- Resistance Level
- BBIO $39.16
- FRHC $157.99
- Average True Range (ATR)
- BBIO 1.50
- FRHC 4.60
- MACD
- BBIO -0.24
- FRHC 1.91
- Stochastic Oscillator
- BBIO 10.35
- FRHC 93.60
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.